Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease.

Kong G, Cao KL, Judd LM, Li S, Renoir T, Hannan AJ.

Neurobiol Dis. 2020 Feb;135:104268. doi: 10.1016/j.nbd.2018.09.001. Epub 2018 Sep 5.

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

Carlozzi NE, Boileau NR, Perlmutter JS, Chou KL, Stout JC, Paulsen JS, McCormack MK, Cella D, Nance MA, Lai JS, Dayalu P.

J Neurol. 2018 Apr 23. doi: 10.1007/s00415-018-8852-5. [Epub ahead of print]

Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition.

Siebzehnrübl FA, Raber KA, Urbach YK, Schulze-Krebs A, Canneva F, Moceri S, Habermeyer J, Achoui D, Gupta B, Steindler DA, Stephan M, Nguyen HP, Bonin M, Riess O, Bauer A, Aigner L, Couillard-Despres

Proc Natl Acad Sci U S A. 2018 Aug 27. pii: 201807962. doi: 10.1073/pnas.1807962115. [Epub ahead of print]

Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI.

Chen L, Hua J, Ross CA, Cai S, van Zijl PCM, Li X.

J Neurosci Res. 2018 Nov 29. doi: 10.1002/jnr.24358. [Epub ahead of print]

Chorea-acanthocytosis: Homozygous 1-kb deletion in VPS13A detected by whole-genome sequencing.

Walker S, Dad R, Thiruvahindrapuram B, Ullah MI, Ahmad A, Hassan MJ, Scherer SW, Minassian BA.

Neurol Genet. 2018 May 18;4(3):e242. doi: 10.1212/NXG.0000000000000242. eCollection 2018 Jun.

Corticostriatal network dysfunction in huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release.

Rebec GV.

CNS Neurosci Ther. 2018 Feb 21. doi: 10.1111/cns.12828. [Epub ahead of print] Review.

Pallidal Deep Brain Stimulation in Patients With Chorea-Acanthocytosis.

Liu Z, Liu Y, Wan X, Yang Y, Wang L, Dou W, Guo J, Wang Y, Guo Y, Ma W, Wang R.

Neuromodulation. 2018 Apr 10. doi: 10.1111/ner.12763. [Epub ahead of print]

Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+/- mouse model of Huntington's Disease.

Goodliffe JW, Song H, Rubakovic A, Chang W, Medalla M, Weaver CM, Luebke JI.

PLoS One. 2018 Aug 17;13(8):e0200626. doi: 10.1371/journal.pone.0200626. eCollection 2018.

Regenerative Approaches in Huntington's Disease: From Mechanistic Insights to Therapeutic Protocols.

Sassone J, Papadimitriou E, Thomaidou D.

Front Neurosci. 2018 Nov 2;12:800. doi: 10.3389/fnins.2018.00800. eCollection 2018. Review.

Population-specific genetic modification of Huntington's disease in Venezuela.

Chao MJ, Kim KH, Shin JW, Lucente D, Wheeler VC, Li H, Roach JC, Hood L, Wexler NS, Jardim LB, Holmans P, Jones L, Orth M, Kwak S, MacDonald ME, Gusella JF, Lee JM.

PLoS Genet. 2018 May 11;14(5):e1007274. doi: 10.1371/journal.pgen.1007274. eCollection 2018 May.

SAP97-mediated rescue of NMDA receptor surface distribution in a neuronal model of Huntington's Disease.

Ambroziak W, Fourie C, Montgomery JM.

Hippocampus. 2018 Aug 1. doi: 10.1002/hipo.22995. [Epub ahead of print]

Leukocyte telomere shortening in Huntington's disease.

Scarabino D, Veneziano L, Peconi M, Frontali M, Mantuano E, Corbo RM.

J Neurol Sci. 2018 Oct 28;396:25-29. doi: 10.1016/j.jns.2018.10.024. [Epub ahead of print]

Huntington's Disease Gene Expansion Carriers Are Aware of Their Degree of Apathy.

Baake V, van Duijn E, Roos RAC.

J Neuropsychiatry Clin Neurosci. 2018 May 30:appineuropsych18020031. doi: 10.1176/appi.neuropsych.18020031. [Epub ahead of print]

Potassium channel dysfunction in neurons and astrocytes in Huntington's disease.

Zhang X, Wan JQ, Tong XP.

CNS Neurosci Ther. 2018 Jan 27. doi: 10.1111/cns.12804. [Epub ahead of print] Review.

Evidence of cardiac electrical remodeling in patients with Huntington disease.

Cankar K, Melik Z, Kobal J, Starc V.

Brain Behav. 2018 Aug;8(8):e01077. doi: 10.1002/brb3.1077. Epub 2018 Jul 20.